We’re back, and SIIM26 is coming…
It’s been a few months since the last edition of the Radiology Rundown, and what a few months it has been. Since we last spoke, I had the pleasure of attending ECR 2026 in Vienna and as always, a brilliant showcase of what is happening across medical imaging in Europe and globally, it’s always a great reminder of just how fast this industry moves. The energy on the floor was fantastic, and the conversations around AI adoption, workflow integration, and clinical validation were sharper than ever.
There’s something special about a conference that returns to the same location every year, and I’m already looking forward to returning to Vienna in 2027. Now, with Society for Imaging Informatics in Medicine (SIIM) 2026 on the horizon, it felt like the perfect time to fire the newsletter back up. If you are heading to SIIM this year and want to connect, please do get in touch. I’d love to see you there.
I’m particularly looking forward to meeting Metric Bio partners; Rad AI , Flywheel.io, FUJIFILM Healthcare Americas Corporation and so many of my network in Pittsburgh next month. In the meantime, there has been no shortage of news to cover. Deals are getting bigger, funding rounds are getting bolder, and the AI conversation in radiology is maturing in genuinely exciting ways. Let’s get into it.
FDA / MARKET APPROVALS
Cognita, the Stanford-founded AI business acquired by Radiology Partnersfor $80 million last November, has received FDA Breakthrough Device designation for its Chest X-ray tool. Radiology Partners believes this to be the first generative vision-language model to assist radiologists in interpreting X-rays to receive the designation, a significant validation of RP’s AI strategy and the technology underpinning it.
Metric Bio partner Butterfly Network, Inc.received FDA clearance for their AI ultrasound pregnancy tool. The model that has been trained on more than 21 million ultrasound images from diverse patient populations and clinical settings, is designed to provide consistent results for pregnancies between 16-37 weeks.
Staying in ultrasound AI, Ligence has received FDA clearance for its AI-powered strain analysis product, a significant milestone for the Lithuanian echocardiography company. Ligence Heart automates cardiac measurements and reporting, and this clearance opens the door to meaningful US market expansion for a product that has already demonstrated strong clinical accuracy. One to watch closely.
FUNDING UPDATES
The biggest investment news has to be that Aidoc has raised $150 million in a Series E round led by Goldman Sachs, with additional contributions from General Catalyst, SoftBank Investment Advisers, and NVentures, Nvidia’s venture capital arm. The New York-based company has now raised over $500 million in total and is deployed at nearly 2,000 hospitals worldwide, supporting care for 60 million patients annually. The funding will accelerate development of Aidoc’s CARE Foundation Model and the buildout of end-to-end automated reporting capabilities. A serious statement of intent from a serious company.
ScreenPoint Medical has secured EUR 13.6 million in fresh funding, comprising EUR 11.9 million from existing investors Insight Partners and Siemens Healthineers , alongside EUR 1.7 million in non-dilutive research grants. The Dutch breast imaging AI company’s Transpara platform is deployed in over 30 countries and has processed more than 12 million mammograms to date. The raise follows landmark clinical evidence: the MASAI randomised controlled trial, published in The Lancet in January 2026, found Transpara contributed to a 12% reduction in interval cancers, with 27% fewer aggressive cancers. Separately, research published in Nature Medicine in March 2026 demonstrated workload reductions of up to 63.6%. Strong clinical evidence backing strong investment.
PARTNERSHIPS & ACQUISITIONS
As announced in the lead up to ECR, RadNet has agreed to acquire Paris-based Gleamer for up to $270 million, in what is one of the most significant radiology AI M&A deals of the year so far. Gleamer’s portfolio spans X-ray, CT, MRI, and mammography across more than 700 customer contracts worldwide. The acquisition will be integrated into RadNet’s DeepHealthsubsidiary, which the company believes will become the largest provider of radiology clinical AI solutions globally as a result. A landmark deal with real market-shaping implications.
Sectra has announced its acquisition of Oxipit, whose ChestLink product holds the first CE Class IIb certification for autonomous AI in chest X-ray analysis. The tool automatically removes high-confidence normal exams from radiologist worklists, freeing up clinician time for the cases that matter most, exactly the kind of workflow innovation the market is calling for.
Azra AI has acquired Thynk Health , a Lexington, Kentucky-based software company focused on lung cancer screening and incidental imaging findings. The combined organisations aim to close the gap between detection and follow-up, ensuring that critical findings lead to timely action for patients rather than falling through the cracks.
Radiology Partners and Stanford Radiology’s AI Development and Evaluation (AIDE) Lab have announced a strategic partnership focused on AI safety, monitoring, and evaluation in medical imaging. The collaboration combines RP’s real-world deployment scale with Stanford’s academic rigour, with joint research already underway. The kind of responsible AI development the industry needs more of.
